In vitro and in vivo characterization of Helicobacter hepaticus cytolethal distending toxin mutants.

Infect Immun

Department of Microbiology and Molecular Genetics, National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan 48824, USA.

Published: May 2004

Helicobacter hepaticus expresses a member of the cytolethal distending toxin (CDT) family of bacterial cytotoxins. To investigate the role of CDT in the pathogenesis of H. hepaticus, transposon mutagenesis was used to generate a series of isogenic mutants in and around the cdtABC gene cluster. An H. hepaticus transposon mutant with a disrupted cdtABC coding region no longer produced CDT activity. Conversely, a transposon insertion outside of the cluster did not affect the CDT activity. An examination of these mutants demonstrated that CDT represents the previously described granulating cytotoxin in H. hepaticus. Challenge of C57BL/6 interleukin 10(-/-) mice with isogenic H. hepaticus mutants revealed that CDT expression is not required for colonization of the murine gut. However, a CDT-negative H. hepaticus mutant had a significantly diminished capacity to induce lesions in this murine model of inflammatory bowel disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC387909PMC
http://dx.doi.org/10.1128/IAI.72.5.2521-2527.2004DOI Listing

Publication Analysis

Top Keywords

helicobacter hepaticus
8
cytolethal distending
8
distending toxin
8
hepaticus transposon
8
cdt activity
8
hepaticus
7
cdt
6
vitro vivo
4
vivo characterization
4
characterization helicobacter
4

Similar Publications

Colorectal cancer (CRC) is one of the most common cancers worldwide. The standard CRC chemo drug, 5-Fluorouracil (5-FU), has a poor response rate and chemoresistance, prompting the need for a more effective and affordable treatment. In this study, we aimed to evaluate whether Prohep, a novel probiotic mixture, would alleviate azoxymethane/dextran sodium sulfate (AOM/DSS)-induced colorectal tumorigenesis and enhance 5-FU efficacy and its mechanism.

View Article and Find Full Text PDF
Article Synopsis
  • * Mice fed a methionine-choline deficient diet to induce NASH were treated with rifaximin, which significantly reduced liver fat, inflammation, and fibrosis.
  • * Rifaximin was found to change gut microbiota and inhibit the intestinal DCA-Fxr-Hnf1α signaling pathway, suggesting its potential for treating NASH clinically.
View Article and Find Full Text PDF
Article Synopsis
  • Obesity is linked to issues like gut microbiota imbalance, inflammation, and intestinal barrier dysfunction, and flavonoids like hesperidin may provide safe anti-obesity solutions.
  • In experiments with high-fat diet (HFD)-fed mice, hesperidin treatment reduced body weight, fat accumulation, inflammation markers, and improved gut health, showing a dose-dependent effect.
  • Both hesperidin and fecal microbiota transplantation (FMT) successfully reduced body weight and addressed HFD-related disorders by altering gut microbiota composition.
View Article and Find Full Text PDF

Heme trafficking is essential for cellular function, yet mechanisms of transport and/or heme interaction are not well defined. The System I and System II bacterial cytochrome c biogenesis pathways are developing into model systems for heme trafficking due to their functions in heme transport, heme stereospecific positioning, and mediation of heme attachment to apocytochrome c. Here we focus on the System II pathway, CcsBA, that is proposed to be a bi-functional heme transporter and holocytochrome c synthase.

View Article and Find Full Text PDF

Objectives: We here assessed whether typical pathogens of laboratory mice affect the development of diet-induced obesity and glucose intolerance, and whether colonization affects the efficacy of the GLP-1R agonist liraglutide and of the GLP-1/GIP co-agonist MAR709 to treat obesity and diabetes.

Methods: Male C57BL/6J mice were experimentally infected with Helicobacter hepaticus, Rodentibacter pneumotropicus and Staphylococcus aureus and compared to a group of uninfected specific and opportunistic pathogen free (SOPF) mice. The development of diet-induced obesity and glucose intolerance was monitored over a period of 26 weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!